Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
34478
Beskrivning
A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01615406
Länk
https://clinicaltrials.gov/show/NCT01615406
Nyckelord
Versioner (3)
- 2019-01-17 2019-01-17 -
- 2019-05-22 2019-05-22 -
- 2019-05-23 2019-05-23 - Sarah Riepenhausen
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
17 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Prostate Cancer NCT01615406
Eligibility Prostate Cancer NCT01615406
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT01615406
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
male aged 21 years or older.
boolean
ID.2
Item
ability to provide signed informed consent and willingness to comply with protocol requirements.
boolean
ID.3
Item
past biopsy indicating the presence of adenocarcinoma of the prostate gland.
boolean
ID.4
Item
participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection.
boolean
ID.5
Item
have had, or will undergo diagnostic ct or mri imaging prior to surgery.
boolean
ID.6
Item
participants must agree to use an acceptable form of birth control throughout the study period. participants must use condoms for a period of seven days after study drug administration, if engaged in sexual activity.
boolean
ID.7
Item
participants for whom participating would significantly delay the scheduled standard of care therapy.
boolean
ID.8
Item
participants administered a radioisotope within 5 physical half lives prior to study enrollment.
boolean
ID.9
Item
participants with any medical condition or other circumstances that, in the opinion of the investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study.
boolean